Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDWD | US
-0.47
-2.67%
Healthcare
Biotechnology
30/06/2024
21/10/2024
17.11
17.36
17.61
16.98
MediWound Ltd. a biopharmaceutical company develops manufactures and commercializes novel bio-therapeutic and non-surgical solutions for tissue repair and regeneration in United States Europe and internationally. It markets NexoBrid a biopharmaceutical product for the removal of eschar a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005 which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne Israel.
View LessStrong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
53.1%1 month
50.4%3 months
56.2%6 months
77.6%-
-
10.93
-
-
-6.32
8.56
-0.07
-14.50M
184.56M
184.56M
-
-88.56
-
6.10
-75.66
13.70
6.28
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.12
Range1M
2.12
Range3M
4.40
Rel. volume
1.06
Price X volume
637.95K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics Inc. Common Stock | TNYA | Biotechnology | 1.92 | 196.12M | -5.88% | n/a | 11.62% |
| Kodiak Sciences Inc | KOD | Biotechnology | 3.67 | 193.10M | 1.38% | n/a | 81.94% |
| Cellectis S.A | CLLS | Biotechnology | 1.835 | 191.88M | -3.42% | n/a | 74.14% |
| Sangamo Therapeutics Inc | SGMO | Biotechnology | 0.913 | 190.11M | -0.84% | n/a | 122.82% |
| Candel Therapeutics Inc. Common Stock | CADL | Biotechnology | 5.84 | 187.38M | -3.63% | n/a | -186.13% |
| DiaMedica Therapeutics Inc | DMAC | Biotechnology | 4.29 | 183.39M | -1.15% | n/a | 0.73% |
| Regulus Resources Inc | RGLSF | Biotechnology | 1.46 | 183.22M | -2.67% | n/a | 0.00% |
| BLACK DIAMOND THERAPEUTICS INC. | BDTX | Biotechnology | 3.21 | 181.38M | -3.02% | n/a | 21.42% |
| Vaxart Inc | VXRT | Biotechnology | 0.7835 | 178.20M | -4.42% | n/a | 28.91% |
| Caribou Biosciences Inc. | CRBU | Biotechnology | 1.97 | 178.01M | -1.50% | n/a | 8.80% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.55 | 145.88M | -0.79% | n/a | 58.43% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.87 | 94.40M | 1.83% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 14.22 | 89.04M | -1.80% | 14.48 | 7.10% |
| Urban One Inc | UONEK | Broadcasting - Radio | 1.01 | 53.54M | -3.35% | n/a | 268.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
| Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.32 | - | Cheaper |
| Ent. to Revenue | 8.56 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 10.93 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 56.23 | - | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 184.56M | - | Emerging |